{"id":"etomidate-injection","safety":{"commonSideEffects":[{"rate":"25-80","effect":"Pain on injection"},{"rate":"25-30","effect":"Transient apnea"},{"rate":"10-20","effect":"Hypotension"},{"rate":"10-30","effect":"Myoclonus"},{"rate":"5-15","effect":"Nausea and vomiting"},{"rate":null,"effect":"Adrenal suppression (with prolonged use)"}]},"_chembl":null,"_dailymed":{"setId":"8b6c54d8-3f3f-4290-841c-976bea01086f","title":"ETOMIDATE (ETOMIDATE INJECTION) SOLUTION [FOSUN PHARMA USA INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Etomidate binds to GABA-A receptors and increases the frequency of chloride channel opening, leading to hyperpolarization of neuronal membranes and rapid onset of unconsciousness. It is primarily used as an intravenous induction agent for anesthesia due to its rapid onset, short duration, and minimal effects on cardiovascular and respiratory stability compared to other induction agents.","oneSentence":"Etomidate is a non-barbiturate hypnotic agent that enhances GABAergic neurotransmission by acting as a positive allosteric modulator at GABA-A receptors in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:37:34.846Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction of general anesthesia"},{"name":"Sedation of intubated patients in intensive care settings"}]},"trialDetails":[{"nctId":"NCT07474545","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Hunan Kelun Pharmaceutical Co., Ltd.","startDate":"2026-03-07","conditions":"Healthy Volunteers","enrollment":76},{"nctId":"NCT07271849","phase":"PHASE4","title":"Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-10-28","conditions":"Postoperative Pain, Acute, Hemodynamics, Total Knee Arthroplasty (TKA)","enrollment":162},{"nctId":"NCT07079176","phase":"NA","title":"Etomidate Combined With Propofol Versus Propofol for Sedation in High-Altitude Patients During Gastroscopy: a Randomized Multicenter Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-08-01","conditions":"Gastrointestinal Endoscopy","enrollment":732},{"nctId":"NCT06682546","phase":"PHASE2","title":"A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy","status":"COMPLETED","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2024-11-15","conditions":"Gastroscopy, Colonoscopy","enrollment":78},{"nctId":"NCT06858852","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy","status":"NOT_YET_RECRUITING","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2025-03","conditions":"Gastroscopy, Colonoscopy","enrollment":270},{"nctId":"NCT06822166","phase":"PHASE1","title":"Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride","status":"COMPLETED","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2023-12-04","conditions":"Interaction Drug Food","enrollment":68},{"nctId":"NCT06822153","phase":"PHASE1","title":"Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart","status":"COMPLETED","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2023-11-09","conditions":"QT Interval, Variation in","enrollment":18},{"nctId":"NCT06822114","phase":"PHASE1","title":"Substance Balance Trial of Methoxyethyl Etomidate Hydrochloride","status":"COMPLETED","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2023-07-17","conditions":"Pharmacokinetics","enrollment":6},{"nctId":"NCT06764147","phase":"PHASE1","title":"Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects","status":"COMPLETED","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2023-12-25","conditions":"Healthy Elderly Subjects","enrollment":16},{"nctId":"NCT05407870","phase":"NA","title":"Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2022-06-09","conditions":"Sedation Complication, Endoscopic Submucosal Dissection, Esophagogastroduodenoscopy","enrollment":138},{"nctId":"NCT06395961","phase":"NA","title":"Effect of New High Ankle Block on Wound Healing After the Operation of Debridement of Diabetes Foot","status":"ENROLLING_BY_INVITATION","sponsor":"Xuzhou Central Hospital","startDate":"2023-08-02","conditions":"Wound Heal, Diabetic Foot Ulcer","enrollment":70},{"nctId":"NCT05223907","phase":"PHASE4","title":"Safety and Efficacy of Maintenance of Etomidate in General Anesthesia","status":"COMPLETED","sponsor":"Henan Provincial People's Hospital","startDate":"2021-05-01","conditions":"General Anesthesia","enrollment":1080},{"nctId":"NCT06203431","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects","status":"UNKNOWN","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2023-10-11","conditions":"Anesthesia Induction","enrollment":270},{"nctId":"NCT06176716","phase":"PHASE1","title":"Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride","status":"UNKNOWN","sponsor":"Ahon Pharmaceutical Co., Ltd.","startDate":"2023-12-06","conditions":"Hepatic Insufficiency","enrollment":24},{"nctId":"NCT05862753","phase":"NA","title":"Duration and Depth of Anesthesia Induced by a Bolus of Etomidate","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2022-01-11","conditions":"Anesthesia","enrollment":18},{"nctId":"NCT05754762","phase":"NA","title":"Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection","status":"UNKNOWN","sponsor":"Yangzhou University","startDate":"2023-03-01","conditions":"Etomidate, Myoclonus","enrollment":70},{"nctId":"NCT05624424","phase":"PHASE4","title":"Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2022-11-15","conditions":"Emergence Agitation, Remimazolam Besylate, Perioperative Sedation","enrollment":1317},{"nctId":"NCT04120870","phase":"NA","title":"Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients","status":"TERMINATED","sponsor":"Ajou University School of Medicine","startDate":"2019-10-01","conditions":"Trauma, Shock, Traumatic","enrollment":10},{"nctId":"NCT03542903","phase":"NA","title":"ECT in Ultra-resistant Schizophrenia","status":"UNKNOWN","sponsor":"Centre Hospitalier du Rouvray","startDate":"2018-07-04","conditions":"Schizophrenia, Electroconvulsive Therapy","enrollment":64},{"nctId":"NCT04054063","phase":"PHASE1","title":"A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male Subjects","status":"COMPLETED","sponsor":"Sichuan Haisco Pharmaceutical Group Co., Ltd","startDate":"2016-11-30","conditions":"General Anesthetic, Sedation","enrollment":25},{"nctId":"NCT02479581","phase":"PHASE2","title":"The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Xiangya Hospital of Central South University","startDate":"2015-07","conditions":"Valvular Heart Disease","enrollment":226},{"nctId":"NCT02807610","phase":"PHASE4","title":"Etomidate vs Propofol-Induction Characteristics","status":"COMPLETED","sponsor":"Maharashtra University of Health Sciences","startDate":"2011-03","conditions":"Hemodynamics, Side Effects","enrollment":100},{"nctId":"NCT02727712","phase":"PHASE4","title":"Studies of Application of Combined General Anesthesia and Bilateral TPVB in OPCABG","status":"UNKNOWN","sponsor":"Xiangya Hospital of Central South University","startDate":"2016-04","conditions":"Coronary Heart Disease","enrollment":60},{"nctId":"NCT02644980","phase":"PHASE4","title":"Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2015-12","conditions":"Delirium, Hemodynamic Instability","enrollment":110},{"nctId":"NCT02473601","phase":"PHASE2","title":"Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2014-10","conditions":"Liver Dysfunction","enrollment":80},{"nctId":"NCT02518789","phase":"PHASE4","title":"Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce Myoclonus","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2015-09","conditions":"Myoclonus","enrollment":132},{"nctId":"NCT02289391","phase":"PHASE4","title":"Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2014-12","conditions":"Anesthesia, Asthma","enrollment":80},{"nctId":"NCT02202239","phase":"PHASE4","title":"Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2014-09","conditions":"Hemodynamics, Oxidative Stress, Anesthesia","enrollment":60},{"nctId":"NCT02134093","phase":"PHASE4","title":"Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2014-07","conditions":"Postoperative Confusion","enrollment":120},{"nctId":"NCT02182648","phase":"PHASE4","title":"Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction","status":"UNKNOWN","sponsor":"Henan Provincial People's Hospital","startDate":"2014-10","conditions":"Bispectral Index, Pediatric, Etomidate","enrollment":120},{"nctId":"NCT02141737","phase":"PHASE4","title":"Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2014-05","conditions":"General Anesthesia","enrollment":272},{"nctId":"NCT02111265","phase":"PHASE4","title":"THe Comparison of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2014-04","conditions":"Adrenal Suppression, Hemodynamic Instability","enrollment":90},{"nctId":"NCT02013986","phase":"PHASE4","title":"Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children","status":"UNKNOWN","sponsor":"Du yi","startDate":"2013-09","conditions":"Congenital Hydronephrosis, Congenital Choledochal Cyst, Fracture","enrollment":30},{"nctId":"NCT01913054","phase":"PHASE4","title":"Combined Use of Etomidate and Propofol in Painless Gastroscopy.","status":"UNKNOWN","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2013-08","conditions":"Safety of Gastroscopy","enrollment":2450},{"nctId":"NCT01729897","phase":"NA","title":"Etomidate Emulsion for Sedation in Patients Scheduled for Upper Gastrointestinal (GI) Endoscopy","status":"COMPLETED","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2012-05","conditions":"Complication of Gastrostomy","enrollment":328},{"nctId":"NCT00862381","phase":"PHASE3","title":"Hydrocortisone Use After Etomidate in Intensive Care","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2008-10","conditions":"Patient Admitted in Reanimation","enrollment":106}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":37,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Etomidate Injection","genericName":"Etomidate Injection","companyName":"Korea University Anam Hospital","companyId":"korea-university-anam-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Etomidate is a non-barbiturate hypnotic agent that enhances GABAergic neurotransmission by acting as a positive allosteric modulator at GABA-A receptors in the central nervous system. Used for Induction of general anesthesia, Sedation of intubated patients in intensive care settings.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}